HK1097406A1 - Selective peroxisome proliferator activated receptor modulators - Google Patents
Selective peroxisome proliferator activated receptor modulatorsInfo
- Publication number
- HK1097406A1 HK1097406A1 HK07102198A HK07102198A HK1097406A1 HK 1097406 A1 HK1097406 A1 HK 1097406A1 HK 07102198 A HK07102198 A HK 07102198A HK 07102198 A HK07102198 A HK 07102198A HK 1097406 A1 HK1097406 A1 HK 1097406A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- activated receptor
- peroxisome proliferator
- proliferator activated
- receptor modulators
- syndrome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03380288 | 2003-12-15 | ||
| US55063604P | 2004-03-05 | 2004-03-05 | |
| PCT/US2004/038232 WO2005061441A1 (en) | 2003-12-15 | 2004-12-08 | Selective peroxisome proliferator activated receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1097406A1 true HK1097406A1 (en) | 2007-06-22 |
Family
ID=34712592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07102198A HK1097406A1 (en) | 2003-12-15 | 2007-02-27 | Selective peroxisome proliferator activated receptor modulators |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7321056B2 (da) |
| EP (1) | EP1697306B1 (da) |
| JP (1) | JP2007516267A (da) |
| KR (1) | KR100806004B1 (da) |
| CN (1) | CN1886364A (da) |
| AT (1) | ATE368026T1 (da) |
| AU (1) | AU2004303793A1 (da) |
| BR (1) | BRPI0417401A (da) |
| CA (1) | CA2549008A1 (da) |
| CY (1) | CY1106846T1 (da) |
| DE (1) | DE602004007825T2 (da) |
| DK (1) | DK1697306T3 (da) |
| EA (1) | EA009023B1 (da) |
| EC (1) | ECSP066639A (da) |
| ES (1) | ES2289589T3 (da) |
| HK (1) | HK1097406A1 (da) |
| HR (1) | HRP20070422T3 (da) |
| IL (1) | IL175997A0 (da) |
| MA (1) | MA28399B1 (da) |
| MX (1) | MXPA06006829A (da) |
| NO (1) | NO20063261L (da) |
| PL (1) | PL1697306T3 (da) |
| PT (1) | PT1697306E (da) |
| SI (1) | SI1697306T1 (da) |
| WO (1) | WO2005061441A1 (da) |
| ZA (1) | ZA200604834B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013049621A1 (en) * | 2011-09-29 | 2013-04-04 | The Board Of Regents Of The University Of Oklahoma | Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof |
| CN106310173A (zh) * | 2016-08-24 | 2017-01-11 | 厦门三川利生物科技有限公司 | 含过氧化物酶体增殖物激活受体多维果酸醇及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| AU3670900A (en) * | 1999-04-08 | 2000-11-14 | Sankyo Company Limited | Substituted fused imidazole derivatives |
| AU2002222552A1 (en) * | 2000-11-29 | 2002-06-11 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| WO2002083616A1 (fr) * | 2001-04-10 | 2002-10-24 | Sankyo Company, Limited | DERIVE D'ACIDE GRAS φomega;-ARYLE α-SUBSTITUE |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| CA2488972A1 (en) * | 2002-06-19 | 2003-12-31 | Eli Lilly And Company | Amide linker peroxisome proliferator activated receptor modulators |
-
2004
- 2004-12-08 WO PCT/US2004/038232 patent/WO2005061441A1/en active Application Filing
- 2004-12-08 EP EP04811083A patent/EP1697306B1/en active Active
- 2004-12-08 KR KR1020067011758A patent/KR100806004B1/ko not_active IP Right Cessation
- 2004-12-08 MX MXPA06006829A patent/MXPA06006829A/es active IP Right Grant
- 2004-12-08 DK DK04811083T patent/DK1697306T3/da active
- 2004-12-08 PT PT04811083T patent/PT1697306E/pt unknown
- 2004-12-08 BR BRPI0417401-1A patent/BRPI0417401A/pt not_active IP Right Cessation
- 2004-12-08 AU AU2004303793A patent/AU2004303793A1/en not_active Abandoned
- 2004-12-08 DE DE602004007825T patent/DE602004007825T2/de active Active
- 2004-12-08 JP JP2006545654A patent/JP2007516267A/ja active Pending
- 2004-12-08 CA CA002549008A patent/CA2549008A1/en not_active Abandoned
- 2004-12-08 US US10/596,256 patent/US7321056B2/en not_active Expired - Fee Related
- 2004-12-08 AT AT04811083T patent/ATE368026T1/de not_active IP Right Cessation
- 2004-12-08 CN CNA2004800355126A patent/CN1886364A/zh active Pending
- 2004-12-08 PL PL04811083T patent/PL1697306T3/pl unknown
- 2004-12-08 ES ES04811083T patent/ES2289589T3/es active Active
- 2004-12-08 EA EA200601159A patent/EA009023B1/ru not_active IP Right Cessation
- 2004-12-08 SI SI200430482T patent/SI1697306T1/sl unknown
-
2006
- 2006-05-29 IL IL175997A patent/IL175997A0/en unknown
- 2006-06-12 ZA ZA200604834A patent/ZA200604834B/en unknown
- 2006-06-14 EC EC2006006639A patent/ECSP066639A/es unknown
- 2006-07-06 MA MA29171A patent/MA28399B1/fr unknown
- 2006-07-13 NO NO20063261A patent/NO20063261L/no not_active Application Discontinuation
-
2007
- 2007-02-27 HK HK07102198A patent/HK1097406A1/xx not_active IP Right Cessation
- 2007-09-05 CY CY20071101149T patent/CY1106846T1/el unknown
- 2007-09-13 HR HR20070422T patent/HRP20070422T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06006829A (es) | 2006-08-23 |
| KR20060121192A (ko) | 2006-11-28 |
| SI1697306T1 (sl) | 2008-02-29 |
| NO20063261L (no) | 2006-09-06 |
| CN1886364A (zh) | 2006-12-27 |
| KR100806004B1 (ko) | 2008-02-26 |
| EP1697306A1 (en) | 2006-09-06 |
| IL175997A0 (en) | 2006-10-05 |
| PL1697306T3 (pl) | 2007-11-30 |
| US7321056B2 (en) | 2008-01-22 |
| CY1106846T1 (el) | 2012-05-23 |
| WO2005061441A1 (en) | 2005-07-07 |
| EA009023B1 (ru) | 2007-10-26 |
| US20070066683A1 (en) | 2007-03-22 |
| HRP20070422T3 (en) | 2007-11-30 |
| ES2289589T3 (es) | 2008-02-01 |
| JP2007516267A (ja) | 2007-06-21 |
| AU2004303793A1 (en) | 2005-07-07 |
| BRPI0417401A (pt) | 2007-05-08 |
| PT1697306E (pt) | 2007-10-19 |
| ZA200604834B (en) | 2007-11-28 |
| DE602004007825T2 (de) | 2008-04-17 |
| ECSP066639A (es) | 2006-10-25 |
| EP1697306B1 (en) | 2007-07-25 |
| EA200601159A1 (ru) | 2006-10-27 |
| DK1697306T3 (da) | 2007-11-12 |
| DE602004007825D1 (de) | 2007-09-06 |
| MA28399B1 (fr) | 2007-01-02 |
| ATE368026T1 (de) | 2007-08-15 |
| CA2549008A1 (en) | 2005-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004011985D1 (de) | Modulatoren des peroxisomproliferatoraktivierten rezeptors | |
| IL159002A0 (en) | Modulators of peroxisome proliferator activated receptors (ppar) | |
| MXPA05008581A (es) | Derivados de sulfonamida como moduladores de ppar. | |
| SI1853266T1 (sl) | 2S,4R ketokonazol za zdravljenje diabetesa, metabolnega sindroma in drugih stanj | |
| WO2007015999A3 (en) | Process for synthesizing a substituted pyrazole | |
| ATE539743T1 (de) | Verfahren zur prävention und behandlung von ppar- vermittelten zuständen mit macelignan | |
| RU2005139525A (ru) | N-ацилированные азотсодержащие гетероциклические соединения в качестве лигандов ppar-рецепторов, активируемых пролифератором пероксисомы | |
| NO20032861L (no) | Heteroarylurea nevropeptid Y Y5-reseptorantagonister | |
| ATE399546T1 (de) | Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1 | |
| ATE401073T1 (de) | Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1 | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| ATE424821T1 (de) | Pyrrolopyridin-2-karbonsäureamide | |
| WO2006014262A3 (en) | Indoles having anti-diabetic activity | |
| MXPA05001712A (es) | Bifenilcarboxamidas sustituidas con n-aril piperidina como inhibidores de la secrecion de apolipoproteina b. | |
| MXPA06011513A (es) | Derivados de indeno y proceso para la preparacion de los mismos. | |
| HK1097406A1 (en) | Selective peroxisome proliferator activated receptor modulators | |
| WO2004037776A3 (en) | Novel compounds and their use as prar-modulators | |
| UA83265C2 (ru) | Селективные модуляторы рецепторов, которые активируются пролифераторами пероксисом | |
| DK1569904T3 (da) | Substituerede arylalkansyrederivater som PPAR pan-agonister med kraftig antihyperglykæmisk og antihyperlipidæmisk aktivitet | |
| WO2005049589A3 (en) | Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20111208 |